<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1703257082
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1995
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DALACIN VAGINAL CREAM 2%
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CLINDAMYCIN PHOSPHATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Vaginal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Vaginal cream
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vaginal Sponge Applicator
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        21
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        35.8
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="PHARMACIA UPJOHN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            PHARMACIA UPJOHN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            PFIZER INC
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        G01AA10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dalacin Cream is a vaginal cream. It contains clindamycin phosphate which is an antibiotic used in the treatment of bacterial vaginosis (a bacterial infection of the vagina).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use Dalacin Cream</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to clindamycin, lincomycin or to any of the other ingredients of this medicine (listed in section 6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have a history of inflammatory bowel disease, regional enteritis or antibiotic-associated colitis.</p><p><strong>&nbsp;</strong></p><p><strong>Take special care with Dalacin Cream</strong></p><p>Talk to your doctor or pharmacist before using this medicine if you:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have diarrhoea or usually get diarrhoea when you take antibiotics or have ever suffered from problems with your stomach or intestines (bowel disease). If you develop severe or prolonged or bloody diarrhoea during or after using Dalacin C Sterile Solution <strong>tell your doctor immediately </strong>since it may be necessary to interrupt the treatment. This may be a sign of bowel inflammation (pseudomembranous colitis) which can occur even after 2 to 3 weeks following treatment with antibiotics.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from problems with your kidneys or liver.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suffer from asthma, eczema or hayfever.</p><p>&nbsp;</p><p>Dalacin vaginal cream 2% contains ingredients that will cause burning and irritation of the eye. In case of accidental contact with the eye, rinse your eye with generous amounts of cool tap water.</p><p>&nbsp;</p><p>The use of Dalacin vaginal cream 2% may result in the overgrowth of nonsusceptible organisms in the vagina that may cause Vaginitis.</p><p>&nbsp;</p><p>As with all vaginal infections, sexual intercourse during treatment with Dalacin Cream is not recommended. Dalacin Cream may weaken condoms and diaphragms. Do not rely on condoms or contraceptive diaphragms within 72 hours following treatment with Dalacin vaginal cream 2% is not recommended.</p><p>&nbsp;</p><p>The use of other vaginal products such as tampons or douches (vaginal washes) during treatment with the cream is not recommended.</p><p>&nbsp;</p><p><strong>Taking other medicines</strong></p><p>Systemic clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patients receiving such agents.</p><p><strong>&nbsp;</strong></p><p>Dalacin cream is not recommended for use in children.</p><p>&nbsp;</p><p>Dalacin Cream may affect other medicines taken at the same time.</p><p>Please tell your doctor if you are taking erythromycin (an antibiotic) or have recently taken any other medicines including medicines obtained without a prescription.</p><p>&nbsp;</p><p><strong>Pregnancy </strong></p><p>If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.</p><p>The use of Dalacin Cream in the first three months of pregnancy is not recommended, as there is insufficient evidence of safety.</p><p>&nbsp;</p><p>Tell your doctor before using this medicine if you are pregnant or think you may be pregnant. If you are pregnant, the cream should only be used after careful discussion with your doctor who will decide if this treatment is appropriate for you.</p><p>&nbsp;</p><p><strong>Nursing Mothers</strong></p><p>Tell your doctor if you will be breast-feeding while using Dalacin Cream as the active substance in this medicine may be passed into breast milk.</p><p>&nbsp;</p><p>Although it is not likely that a nursing infant will take in very much of the active substance from the milk he drinks, if your baby gets bloodstained diarrhea or shows any signs of illness, tell your doctor at once. You should stop breast-feeding if this happens.</p><p>&nbsp;</p><p><strong>Pediatric Use</strong></p><p>Dalacin Cream 2% is not recommended for use in children.</p><p>&nbsp;</p><p><strong>Dalacin Cream 2% contains propylene glycol and cetostearyl alcohol</strong></p><p>Dalacin Cream contains propylene glycol and cetostearyl alcohol which may cause local skin irritation and inflammation.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always wash your hands before using the cream.</p><p>The recommended dose is one applicatorful of Dalacin vaginal cream 2%, (5 grams containing approximately 100 mg of clindamycin phosphate) intravaginally, preferably at bedtime, for 3 or 7 consecutive days in non-pregnant patients and for 7 consecutive days in pregnant patients.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Insertion:</strong></p><p>Disposable plastic applicators are provided with this package. They are designed to allow proper vaginal administration of the cream.</p><p>&nbsp;</p><p>Remove cap from cream tube. Screw a plastic applicator on the threaded end of the tube.</p><p>&nbsp;</p><p>Rolling tube from the bottom, squeeze gently and force the medication into the applicator. The applicator is filled when the plunger reaches its predetermined stopping point.</p><p>&nbsp;</p><p>Unscrew the applicator from the tube and replace the cap.</p><p><strong>&nbsp;</strong></p><p><strong><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600"
 o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f"
 stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="Picture_x0020_3" o:spid="_x0000_i1026" type="#_x0000_t75"
 alt="Cleocin Vag Image 02" style='width:163.2pt;height:106.8pt;visibility:visible;
 mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.jpg"
  o:title="Cleocin Vag Image 02"/>
</v:shape><![endif]--><img width="218" height="142" alt="Cleocin Vag Image 02" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image001.jpg" /></strong></p><p><strong>&nbsp;</strong></p><p>While lying on your back, firmly grasp the applicator barrel and insert into vagina as far as possible without causing discomfort.</p><p>&nbsp;</p><p>Slowly push the plunger until it stops.</p><p><strong>&nbsp;</strong></p><p><strong><!--[if gte vml 1]><v:shape
 id="Picture_x0020_2" o:spid="_x0000_i1025" type="#_x0000_t75" alt="Cleocin Vag Image 03"
 style='width:229.8pt;height:157.8pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image002.jpg"
  o:title="Cleocin Vag Image 03"/>
</v:shape><![endif]--><img width="306" height="210" alt="Cleocin Vag Image 03" src="file:///C:/Users/ibrahw02/AppData/Local/Temp/1/msohtmlclip1/01/clip_image002.jpg" /></strong></p><p><strong>&nbsp;</strong></p><p>Carefully withdraw applicator from vagina, and discard applicator.</p><p><strong>&nbsp;</strong></p><p>REMEMBER TO APPLY ONE APPLICATORFUL EACH NIGHT BEFORE BEDTIME, OR AS PRESCRIBED BY YOUR DOCTOR.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p><strong>If you use more Dalacin Cream than you should</strong></p><p>Tell your doctor. Do not use any more cream until your doctor tells you to.</p><p>&nbsp;</p><p><strong>If you swallow Dalacin Cream:</strong></p><p>If you or somebody else swallows some Dalacin Cream, contact your doctor. The cream is not likely to cause any harm, but your doctor will be able to give you advice on what to do.</p><p>&nbsp;</p><p><strong>If you miss a dose of Dalacin Cream:</strong></p><p>If the forgotten dose is just a few hours late, use it straight away.</p><p>If it is nearly time for your next application, miss out the forgotten one. Do the next application at the normal time. Do not use double the amount but carry on using your Cream at the usual times.</p><p>&nbsp;</p><p><strong>&nbsp;If you stop taking Dalacin Cream:</strong></p><p>Sometimes you may feel better after only a few days treatment. Even if you do feel better, do not stop using the cream until you have completed the full course of treatment.</p><p>If you have any further questions on how to take this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Tell your doctor immediately</strong> if you:</p><p>&bull; Develop severe, sometimes bloody diarrhea (which may be associated with stomach pain or fever). This is an uncommon side effect that may occur after treatment with antibiotics and can be a sign of serious bowel inflammation.</p><p>&bull; experience an allergic reaction or skin reaction such as hives or a measles-like rash. These are Uncommon side effects.</p><p>&nbsp;</p><p>&nbsp;Common: may affect up to 1 in 10 people</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaginal thrush</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Infection or inflammation of the vulva and vagina</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Vaginal disorder, Vaginal discomfort, vaginal discharge</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fungal infection of the body as a whole</p><p>&nbsp;</p><p>Uncommon: may affect up to 1 in 100 people</p><p>&nbsp;</p><p><em>Urogenital system:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vaginal discharge,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heavy bleeding during period,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; urinary tract infection,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; endometriosis,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; menstrual disorder,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; vaginitis/vaginal infection, and vaginal pain.</p><p>&nbsp;</p><p><em>Body as a whole: </em></p><ul><li>localized abdominal pain, generalized abdominal pain, abdominal cramps,</li><li>bad breath,</li><li>headache,</li><li>bacterial infection,</li><li>inflammatory swelling, allergic reaction,</li><li>fungal infection.</li></ul><p>&nbsp;</p><p><em>Digestive system: </em></p><ul><li>nausea, vomiting, constipation,</li><li>dyspepsia, flatulence, diarrhea, and gastrointestinal disorder.</li></ul><p>&nbsp;</p><p><em>Endocrine system: </em></p><ul><li>hyperthyroidism.</li></ul><p>&nbsp;</p><p><em>Central nervous system: </em></p><ul><li>dizziness and vertigo.</li></ul><p>&nbsp;</p><p><em>Respiratory system: </em></p><ul><li>bleeding from the nose.</li></ul><p>&nbsp;</p><p><em>Skin: </em></p><ul><li>Itchy skin (non-application site), moniliasis, rash, skin redness, and urticaria.</li></ul><p>&nbsp;</p><p><em>Special senses:</em></p><ul><li>taste perversion.</li></ul><p>&nbsp;</p><p>Not known: frequency cannot be estimated from available data</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the lining of large intestine (pseudomembranous colitis due to <em>Clostridioides difficile</em>)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cases of severe reaction affecting the skin, blood and internal organs had been reported</p><ul><li>Cases of polyarthritis have been reported.</li><li>Acute kidney injury</li></ul><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p><strong>To Report side effects</strong></p><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp; Call center: 19999</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep out of the reach and sight of children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shelf life: 21 months.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Dalacin Cream after the expiry date which is stated on the tube and carton. The expiry date refers to the last day of that month.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Store below 25<sup>&deg;</sup>C. Protect from freezing.</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vaginal cream 2%, is a semi-solid, white cream, which contains 2% clindamycin phosphate, USP, at a concentration equivalent to 20 mg clindamycin per gram. The cream also contains benzyl alcohol, cetostearyl alcohol, mixed fatty acid esters, mineral oil, polysorbate 60, propylene glycol, purified water, sorbitan monostearate, and stearic acid.</p><p>&nbsp;</p><p>Each applicatorful of 5 grams of vaginal cream contains approximately 100 mg of clindamycin phosphate</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Dalacin vaginal cream 2%, is supplied as follows:
40 gram tube (with 7 disposable applicators)

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>MARKETING AUTHORISATION HOLDER</strong></p><p>Pfizer Inc, New York, United States</p><p>&nbsp;</p><p><strong>MANUFACTURED BY</strong></p><p>Pharmacia &amp; Upjohn Company LLC</p><p>Kalamazoo, Michigan 49001, USA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                May 2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">كريم دالاسين هو كريم مهبلي. يحتوي على فوسفات الكلينداميسين الذي يُعد مضادًا حيويًا يُستخدم في علاج العدوى البكتيرية المهبلية (عدوى بكتيرية تصيب المهبل).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>موانع استعمال دالاسين</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ مصابة بحساسية تجاه كلينداميسين، أو لينكوميسين، أو أي من المكونات الأخرى لهذا الدواء (المدرجة في القسم ٦).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديكِ تاريخ من الإصابة بمرض التهاب الأمعاء، أو التهاب الأمعاء الناحي، أو التهاب القولون المرتبط بالمضادات الحيوية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الاحتياطات عند استعمال دالاسين</strong></p><p dir="RTL">تحدثي إلى الطبيب أو الصيدلي قبل استخدام هذا الدواء إذا كنتِ تعانين من:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال أو عادةً ما تصابين به عندما تتناولين المضادات الحيوية أو إذا سبق أن عانيتِ من مشكلات في معدتكِ أو أمعائكِ (مرض الأمعاء). إذا أُصبتِ بإسهال شديد أو طويل الأمد أو مختلط بالدم أثناء استخدام محلول دالاسين سي المعقم أو بعد استخدامه، <strong>فأخبري طبيبكِ على الفور</strong> لأنه قد يكون من الضروري إيقاف العلاج. قد يكون هذا الأمر علامة للإصابة بالتهاب الأمعاء (التهاب القولون الغشائي الكاذب) الذي يمكن أن يحدث حتى بعد فترة تتراوح من أسبوعين إلى ٣ أسابيع تلي العلاج باستخدام المضادات الحيوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلات بالكلى أو الكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الربو، أو الإكزيما، أو حمى القش.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كريم دالاسين المهبلي ٢ ٪ على مكونات تسبب حرقة وهياجًا بالعين. في حالة حدوث تلامس عرضي مع العين، اغسلي عينكِ بكميات وفيرة من ماء الصنبور البارد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن يؤدي استخدام كريم دالاسين المهبلي ٢ ٪ إلى زيادة معدلات نمو الكائنات غير الحساسة في المهبل التي يمكن أن تسبب التهاب المهبل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما هو الحال مع جميع حالات العدوى المهبلية، لا يوصى بممارسة الجنس أثناء العلاج باستخدام كريم دالاسين. قد يُضعف كريم دالاسين الواقيات الذكرية والحواجز الأنثوية. لا تعتمد على الواقيات الذكرية أو الحواجز الأنثوية المانعة للحمل خلال ٧٢ ساعة تلي العلاج باستخدام كريم دالاسين المهبلي ٢ ٪ ولا يوصى باستخدامها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يوصى باستخدام المنتجات المهبلية الأخرى مثل السدادات القطنية أو منتجات الشطف (الغسول المهبلي) أثناء العلاج باستخدام الكريم.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">ثبت أن لكلينداميسين المُستخدم جهازيًا خصائص حاصرة للوصل العضلي العصبي يمكن أن تعزز تأثير العوامل الأخرى الحاصرة للوصل العضلي العصبي. ولذلك، ينبغي استخدامه بحذر مع المرضى الذين يتلقون مثل هذه الأدوية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يوصى باستخدام كريم دالاسين في الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يؤثر كريم دالاسين على الأدوية الأخرى التي يتم تناولها بالتزامن معه.</p><p dir="RTL">يرجى إخبار طبيبكِ إذا كنتِ تتناولين إريثروميسين (وهو مضاد حيوي) أو تناولتِ مؤخرًا أي أدوية أخرى بما في ذلك الأدوية التي يمكن الحصول عليها بدون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">إذا كنتِ حاملًا، أو تعتقدين أنكِ قد تكونين حاملًا، أو تخططين للإنجاب، فاستشيري طبيبكِ أو الصيدلي قبل استخدام هذا الدواء.</p><p dir="RTL">يوصى بعدم استخدام كريم دالاسين في الأشهر الثلاثة الأولى من الحمل، حيث إنه لا توجد أدلة كافية على سلامة هذا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبري طبيبكِ قبل استخدام هذا الدواء إذا كنتِ حاملًا أو تعتقدين أنكِ ربما تكونين حاملًا. إذا كنتِ حاملًا، ينبغي فقط استخدام الكريم بعد مناقشة دقيقة مع طبيبكِ الذي سيقرر ما إذا كان العلاج ملائمًا لكِ أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأمهات المرضعات</strong></p><p dir="RTL">أخبري طبيبكِ إذا كنت سترضعين رضاعة طبيعية أثناء استخدام كريم دالاسين حيث إن المادة الفعالة في هذا الدواء يمكن أن تمر إلى لبن الثدي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">على الرغم من أنه من غير المرجح أن يتلقى الطفل الرضيع كمية كبيرة من المادة الفعالة عبر اللبن الذي يشربه، أخبري طبيبكِ فورًا إذا أصيب طفلكِ بإسهال مخلوط بدم أو ظهرت عليه أي علامات على المرض. ينبغي أن تتوقفي عن الرضاعة الطبيعية إذا حدث هذا.</p><p dir="RTL">&nbsp;</p><p>الاستعمال في الأطفال</p><p dir="RTL">لا يوصى باستعمال كريم دالاسين ٢ ٪ للأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات دالاسين</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كريم دالاسين ٢ ٪ على بروبيلين جليكول وكحول سيتوستياريلي مما قد يسبب تهيج الجلد والالتهابه.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">اغسلي يديكِ دائمًا قبل استخدام الكريم</p><p dir="RTL">الجرعة الموصى بها هي ملء أداة إدخال واحدة من كريم دالاسين المهبلي ٢ ٪، (٥ جرام تحتوي على ١٠٠ ملجم تقريبًا من فوسفات الكليندمايسين) داخل المهبل، يُفضل وقت الخلود إلى النوم، لمدة ٣ أو ٧ أيام متتالية في المريضات غير الحوامل ولمدة ٧ أيام متتالية في المريضات الحوامل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإدخال:</strong></p><p dir="RTL">مرفق في هذه العبوة أدوات إدخال بلاستيكية للاستخدام مرة واحدة. أدوات الإدخال هذه مصممة بحيث تسمح باستعمال الكريم المهبلي بطريقة صحيحة.</p><p dir="RTL">أزيلي الغطاء عن أنبوب الكريم. اربطي إحدى أدوات الإدخال البلاستيكية على الطرف اللولبي المفتوح من الأنبوب.</p><p dir="RTL">لفي الأنبوب من الأسفل، واضغطي برفق لدفع الدواء إلى داخل أداة الإدخال. تكون أداة الإدخال ممتلئة بالكامل عند وصول المكبس إلى نقطة توقفه المحددة مسبقًا.</p><p dir="RTL">قومي بفك أداة الإدخال من الأنبوب وأعيدي وضع الغطاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">استلقي على ظهرك، وأمسكي جسم أداة الإدخال بإحكام، وأدخليها برفق في المهبل لأقصى حد ممكن بحيث لا تسبب لك الانزعاج.</p><p dir="RTL">اضغطي برفق على المكبس حتى يتوقف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">اسحبي أداة الإدخال برفق من المهبل وتخلصي منها.</p><p dir="RTL">&nbsp;</p><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>المستقيم</strong></p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>عنق الرحم</strong></p></td></tr></tbody></table><table cellpadding="0" cellspacing="0" style="width:100%"><tbody><tr><td><p dir="RTL"><strong>المهبل</strong></p></td></tr></tbody></table><p>&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">تذكري استخدام ملء أداة إدخال واحدة من الدواء كل ليلة قبل الخلود إلى النوم أو وفقًا لوصف طبيبك.</p><p dir="RTL"><strong>الجرعة الزائدة من دالاسين</strong></p><p dir="RTL">أخبري طبيبكِ. لا تستخدمي أي كريم إضافي حتى يخبركِ الطبيب بفعل ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا ابتلعتِ كريم دالاسين:</strong></p><p dir="RTL">اتصلي بطبيبكِ إذا قمتِ، أو قام شخص آخر، بابتلاع بعض من كريم دالاسين. ليس من المرجح أن يسبب الكريم أي ضرر، ولكن سيتمكن طبيبكِ أن يقدم لكِ النصح بشأن ما يجب عليكِ فعله.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نسيان تناول جرعة دلاسين:</strong></p><p dir="RTL">إذا تأخرتِ بضع ساعات فقط عن موعد استخدام الجرعة المنسية، فاستخدميها على الفور.</p><p dir="RTL">وإذا كان موعد وضع الجرعة التالية قد اقترب، فتخطي الجرعة التي نسيتها. قومي بوضع الكريم في الموعد المعتاد لذلك. لا تضاعفي الكمية المستخدمة، بل واصلي استخدام الكريم في الأوقات المعتادة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;التوقف عن تناول دالاسين:</strong></p><p dir="RTL">في بعض الأحيان قد تشعرين بتحسن بعد بضعة أيام فقط من العلاج. حتى إذا شعرتِ بتحسن، فلا تتوقفي عن استخدام الكريم إلا بعد إكمال دورة العلاج بالكامل.</p><p dir="RTL">إذا كان لديكِ المزيد من الأسئلة حول كيفية استخدام هذا المنتج، فاسألي طبيبكِ أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، على الرغم من أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبري طبيبكِ على الفور في</strong> الحالات التالية:</p><p dir="RTL">&bull; إذا أصبتِ بإسهال شديد بعض الاحيان مخلوط بدم (والذي قد يكون مصحوبًا بألم في المعدة أو حمى). يُعد هذا أحد الآثار الجانبية غير الشائعة التي قد تحدث بعد العلاج بالمضادات الحيوية، ويمكن أن يكون علامة على وجود التهاب خطير في الأمعاء.</p><p dir="RTL">&bull; إذا أصبتِ بتفاعل حساسية أو تفاعل جلدي أو طفح شبيه بالحصبة. تعد هذه الآثار الجانبية غير شائعة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">شائعة: قد تصيب ما يصل إلى شخص واحد من بين ١٠ أشخاص</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; القلاع المهبلي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى أو التهاب الفرج والمهبل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحكة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب بالمهبل، انزعاج بالمهبل، الإفرازات المهبلية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى فطرية في الجسم بأكمله</p><p dir="RTL">&nbsp;</p><p dir="RTL">غير شائعة: قد تصيب ما يصل إلى شخص واحد من بين ١٠٠ شخص</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>الجهاز البولي التناسلي:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإفرازات المهبلية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النزيف الشديد أثناء الدورة الشهرية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى المسالك البولية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتباذ بطانة الرحم،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب الدورة الشهرية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب المهبل/عدوى المهبل، وألم بالمهبل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><em>في الجسم كله:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم موضعي بالبطن، وألم معمم بالبطن، وتقلصات (تشنجات) بالبطن،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رائحة نفس كريهة،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى بكتيرية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم التهابي، تفاعل حساسية،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى فطرية.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الجهاز الهضمي:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غثيان، قيء، إمساك،</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوء هضم، وامتلاء البطن بالغازات، وإسهال، واضطرابات معدية معوية.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>جهاز الغدد الصماء:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط نشاط الغدة الدرقية.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الجهاز العصبي المركزي:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دوار ودوخة.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الجهاز التنفسي:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف من الأنف.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الجلد:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة الجلد (في غير موضع الاستخدام)، وداء المبيضات، والطفح الجلدي، واحمرار الجلد، والارتيكاريا.</p><p dir="RTL"><em>&nbsp;</em></p><p dir="RTL"><em>الحواس الخاصة:</em></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلل في حاسة التذوق.</p><p dir="RTL">&nbsp;</p><p dir="RTL">غير معروفة: لا يمكن تقدير معدل التكرار من البيانات المتاحة</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب بطانة الأمعاء الغليظة (التهاب القولون الغشائي الكاذب بسبب المطثية العسيرة (كلوستريديويديس ديفيسيل))</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن حالات من التفاعلات الشديدة التي تؤثر على الجلد، والدم، والأعضاء الداخلية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تم الإبلاغ عن حالات من التهاب المفاصل</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إصابة الكلى الحادة</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا ظهرت عليكِ أي أعراض جانبية، فتحدثي إلى طبيبكِ أو الصيدلي. يشمل هذا أي أعراض جانبية محتملة وغير مدرجة في هذه النشرة. بالإبلاغ عن الآثار الجانبية، يمكنكِ المساعدة في توفير المزيد من المعلومات حول مأمونية هذا الدواء</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp; </strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL">&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المركز الوطني للتيقظ الدوائي</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال الموحد: ١٩٩٩٩</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع الإلكتروني: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>دول الخليج الأخرى</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0" align="right" style="width:582px"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><em>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em><em>الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</em></p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull; يحفظ بعيدًا عن متناول ومرأى الأطفال.</p><p dir="RTL">&bull; صلاحية المستحضر: ٢١ شهر.</p><p dir="RTL">&bull; لا تستخدمي كريم دالاسين بعد تاريخ انتهاء الصلاحية المبين على الأنبوب والعبوة الكرتونية. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&bull; يُخزن في درجة حرارة أقل من ٢٥ درجة مئوية. يجب حمايته من التجمد.</p><p dir="RTL">&bull; ينبغي عدم التخلص من الأدوية عبر ماء الصرف أو في القمامة المنزلية. اسألي الصيدلي عن كيفية التخلص من الأدوية التي لم تعد هناك حاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كريم دالاسين المهبلي ٢ ٪ هو كريم أبيض اللون شبه صلب، يحتوي على فوسفات الكلينداميسين ٢ ٪، وفقًا للدستور الأمريكي للأدوية، بتركيز يعادل ٢٠ ملجم من كلينداميسين لكل جرام. تتراوح درجة حموضة (pH) الكريم بين ٣ و٦. يحتوي الكريم أيضًا على كحول بنزيلي وكحول سيتوستياريلي وإسترات أحماض دهنية مختلطة وزيت معدني وبولي سوربات ٦٠ وبروبيلين جليكول وماء مُنقَّى وسوربيتان أحادي الستيارات وحمض الستياريك.</p><p dir="RTL">تحتوي الكمية المستخدمة لملء أداة إدخال واحدة كاملة وقدرها ٥ جرامات من الكريم المهبلي على ١٠٠ ملجم من فوسفات الكلينداميسين تقريبًا.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتم توفير كريم دالاسين المهبلي ٢ ٪ كالتالي:</p><p dir="RTL">أنبوب ٤٠ جرام (مزود بـ ٧ أدوات إدخال للاستخدام مرة واحدة)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق</strong></p><p dir="RTL">Pfizer Inc, New York, United States</p><p dir="RTL">الولايات المتحدة الأمريكية</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المصنّعة</strong></p><p dir="RTL">فارماسيا أند أبجون كومبني ال ال سي</p><p dir="RTL">كلامازوو، ميتشجان ٤٩٠٠١، الولايات المتحدة الأمريكية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مايو/أيار ٢٠٢٢
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dalacin Vaginal Cream 2%
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Clindamycin phosphate is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α−D-galacto-octopyranoside 2-(dihydrogen phosphate). It has a molecular weight of 504.96, and the molecular formula is C18H34ClN2O8PS. The structural formula is represented below:
 
Dalacin Vaginal Cream 2%, is a semi-solid, white cream, which contains 2% clindamycin phosphate, USP, at a concentration equivalent to 20 mg clindamycin per gram. The pH of the cream is between 3.0 and 6.0. The cream also contains benzyl alcohol, cetostearyl alcohol, mixed fatty acid esters, mineral oil, polysorbate 60, propylene glycol, purified water, sorbitan monostearate, and stearic acid.

Each applicatorful of 5 grams of vaginal cream contains approximately 100 mg of clindamycin phosphate.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vaginal cream. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dalacin Vaginal Cream 2%<strong> </strong>is indicated in the treatment of bacterial vaginosis (formerly referred to as <u>Haemophilus</u> vaginitis, <em>Gardnerella</em> vaginitis, nonspecific vaginitis,<em> Corynebacterium </em>vaginitis, or anaerobic vaginosis).</p><p>Dalacin Vaginal Cream 2%, can be used to treat non-pregnant women and pregnant women during their second and third trimester.</p><p><strong>&nbsp;</strong></p><p><strong>NOTE: </strong>For purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a pH of greater than 4.5, (b) emits a &quot;fishy&quot; amine odor when mixed with a 10% KOH solution, and (c) contains clue cells on microscopic examination. Gram&#39;s stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent <em>Lactobacillus </em>morphology, (b) predominance of <em>Gardnerella </em>morphotype, and (c) absent or few white blood cells.</p><p>Other pathogens commonly associated with vulvovaginitis, eg., <em>Trichomonas vaginalis, Chlamydia trachomatis, N. gonorrhoeae, Candida albicans, </em>and <em>Herpes simplex </em>virus should be ruled out.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The recommended dose is one applicatorful of clindamycin phosphate vaginal cream 2%, (5 grams containing approximately 100 mg of clindamycin phosphate) intravaginally, preferably at bedtime, for 3 or 7 consecutive days in non-pregnant patients and for 7 consecutive days in pregnant patients. (See section 5.1 Pharmacological properties)</p><p>&nbsp;</p><p><strong>FOR INTRAVAGINAL USE ONLY</strong></p><p><strong>&nbsp;</strong></p><p><strong>NOT FOR OPHTHALMIC, DERMAL, OR ORAL USE</strong></p><p><strong>&nbsp;</strong></p><p><strong>DIRECTIONS FOR USE</strong></p><p><strong>&nbsp;</strong></p><p>Disposable plastic applicators are provided with this package. They are designed to allow proper vaginal administration of the cream.</p><p>&nbsp;</p><p>Remove cap from cream tube. Screw a plastic applicator on the threaded end of the tube.</p><p>&nbsp;</p><p>Rolling tube from the bottom, squeeze gently and force the medication into the applicator. The applicator is filled when the plunger reaches its predetermined stopping point.</p><p>&nbsp;</p><p>Unscrew the applicator from the tube and replace the cap.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p>While lying on your back, firmly grasp the applicator barrel and insert into vagina as far as possible without causing discomfort.</p><p>&nbsp;</p><p>Slowly push the plunger until it stops.</p><p>&nbsp;</p><p>Carefully withdraw applicator from vagina, and discard applicator.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p>REMEMBER TO APPLY ONE APPLICATORFUL EACH NIGHT BEFORE BEDTIME, OR AS PRESCRIBED BY YOUR DOCTOR.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dalacin Vaginal Cream 2% is contraindicated in patients with a history of hypersensitivity to clindamycin, lincomycin or any of the components of this vaginal cream. Dalacin Vaginal Cream 2%, is also contraindicated in individuals with a history of “antibiotic-associated colitis” or a history of regional enteritis, ulcerative colitis. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>WARNINGS</strong></p><p><strong>Pseudomembranous colitis has been reported with nearly all antibacterial agents, including clindamycin, and may range in severity from mild to life-threatening. Orally and parenterally administered clindamycin has been associated with severe colitis which may end fatally. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of orally and parenterally administered clindamycin, as well as with topical (dermal and vaginal) formulations of clindamycin. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of clindamycin, even when administered by the vaginal route, because approximately 5% of the clindamycin dose is systemically absorbed from the vagina.</strong></p><p>&nbsp;</p><p>Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by <em>Clostridioides</em><em> </em><em>difficile</em> is a primary cause of &ldquo;antibiotic-associated&rdquo; colitis.</p><p>&nbsp;</p><p>After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to discontinuation of the drug alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation, and treatment with an antibacterial drug clinically effective against <em>Clostridioides difficile</em> colitis.</p><p>&nbsp;</p><p>Onset of pseudomembranous colitis symptoms may occur during or after antimicrobial treatment.</p><p>&nbsp;</p><p><strong>PRECAUTIONS</strong></p><p>&nbsp;</p><p>Dalacin Vaginal Cream 2%, contains ingredients that will cause burning and irritation of the eye. In the event of accidental contact with the eye, rinse the eye with copious amounts of cool tap water.</p><p>&nbsp;</p><p>The use of Dalacin Vaginal Cream 2% may result in the overgrowth of nonsusceptible organisms in the vagina. In clinical studies involving 600 non-pregnant women who received treatment for 3 days, <em>Candida albicans</em> was detected, either symptomatically or by culture, in 8.8% of patients. In 9% of the patients, vaginitis was recorded. In clinical studies involving 1325 non-pregnant women who received treatment for 7 days, <em>Candida albicans</em> was detected, either symptomatically or by culture, in 10.5% of patients. Vaginitis was recorded in 10.7% of the patients. In 180 pregnant women who received treatment for 7 days, <em>Candida albicans</em> was detected, either symptomatically or by culture, in 13.3% of patients. In 7.2% of the patients, vaginitis was recorded. <em>Candida albicans</em>, as reported here, includes the terms: vaginal moniliasis and moniliasis (body as a whole). Vaginitis includes the terms: vulvovaginal disorder, vulvovaginitis, vaginal discharge, trichomonal vaginitis, and vaginitis.</p><p>&nbsp;</p><p><strong>Information for the Patient:</strong></p><p>&nbsp;</p><p>The patient should be instructed not to engage in vaginal intercourse, or use other vaginal products (such as tampons or douches) during treatment with this product.</p><p>&nbsp;</p><p><strong>The patient should also be advised that this cream contains mineral oil that may weaken latex or rubber products such as condoms or vaginal contraceptive diaphragms. Therefore, use of such products within 72 hours following treatment with Dalacin Vaginal Cream 2%, is not recommended.</strong></p><p>&nbsp;</p><p><strong>Pediatric Use</strong></p><p>&nbsp;</p><p>Safety and efficacy in pediatric patients have not been established.</p><p>&nbsp;</p><p>Geriatric Use</p><p>&nbsp;</p><p>Clinical studies for clindamycin phosphate vaginal cream 2% did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Systemic clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore, it should be used with caution in patients receiving such agents.</p><p>&nbsp;</p><p>Cross resistance has been demonstrated between clindamycin and lincomycin, and erythromycin and clindamycin. Antagonism has been demonstrated between clindamycin and erythromycin <em>in vitro</em>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis, Mutagenesis, Impairment of Fertility</p><p>&nbsp;</p><p>Long term studies in animals have not been performed with clindamycin to evaluate carcinogenic potential. Genotoxicity tests performed included a rat micronucleus test and an Ames test. Both tests were negative. Fertility studies in rats treated orally with up to 300 mg/kg/day (31 times the human exposure based on mg/m<sup>2</sup>) revealed no effects on fertility or mating ability.</p><p>&nbsp;</p><p><strong>Pregnancy: Teratogenic effects</strong></p><p>&nbsp;</p><p>In clinical trials with pregnant women, the systemic administration of clindamycin during the second and third trimesters, has not been associated with an increased frequency of congenital abnormalities.</p><p>&nbsp;</p><p>Clindamycin vaginal cream should be used during the first trimester of pregnancy only if clearly needed and the benefits outweigh the risks. There are no adequate and well-controlled studies in pregnant women during the first trimester of pregnancy.</p><p>&nbsp;</p><p>Dalacin Vaginal Cream 2% has been studied in pregnant women during the second trimester. In women treated for seven days, abnormal labor was reported in 1.1% of patients who received clindamycin vaginal cream 2% compared with 0.5% of patients who received placebo.</p><p>&nbsp;</p><p>Reproduction studies have been performed in rats and mice using oral and parenteral doses of clindamycin up to 600 mg/kg/day (62 and 25 times, respectively, the maximum human exposure based on body surface area and have revealed no evidence of harm to the fetus due to clindamycin. Cleft palates were observed in fetuses from one mouse strain treated intraperitoneally with clindamycin at 200 mg/kg/day (about 10 times the recommended dose based on body surface area conversions). Since this effect was not observed in other mouse strains or in other species, the effect may be strain specific.</p><p>&nbsp;</p><p><strong>Nursing Mothers</strong></p><p>&nbsp;</p><p>Limited published data based on breast milk sampling reports that clindamycin appears in human breast milk in the range of less than 0.5 to 3.8 mcg/mL at dosages of 150 mg orally to 600 mg intravenously. It is not known if clindamycin is excreted in human milk following the use of vaginally administered clindamycin phosphate.</p><p>&nbsp;</p><p>Clindamycin has the potential to cause adverse effects on the breast-fed infant&#39;s gastrointestinal flora. If clindamycin is required by a nursing mother, it is not a reason to discontinue breastfeeding, but an alternate drug may be preferred. Monitor the breast-fed infant for possible adverse effects on the gastrointestinal flora, such as diarrhea, candidiasis (thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis.</p><p>&nbsp;</p><p>The developmental and health benefits of breastfeeding should be considered along with the mother&#39;s clinical need for clindamycin and any potential adverse effects on the breast-fed child from clindamycin or from the underlying maternal condition.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clinical trials</p><p>Non-pregnant Women:<strong> </strong>In clinical trials involving non-pregnant women, 1.8% of 600 patients who received treatment with Dalacin Vaginal Cream 2% for 3 days and 2.7% of 1325 patients who received treatment for 7 days discontinued therapy due to drug-related adverse events. Medical events judged to be related, probably related, possibly related, or of unknown relationship to vaginally administered clindamycin phosphate vaginal cream 2%, were reported for 20.7% of the patients receiving treatment for 3 days and 21.3% of the patients receiving treatment for 7 days. Events occurring in &ge;1% of patients receiving clindamycin phosphate vaginal cream 2% are shown in Table 1.</p><p>&nbsp;</p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:582px"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>TABLE 1 &ndash; Events Occurring in &ge;1% of Non-pregnant Patients Receiving</strong></p><p><strong>Clindamycin Phosphate Vaginal Cream 2%</strong></p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>Dalacin Vaginal Cream</p></td></tr><tr><td style="vertical-align:top"><p>Event</p></td><td style="vertical-align:top"><p>3 Day</p><p>n=600</p></td><td style="vertical-align:top"><p>7 Day</p><p>n=1325</p></td></tr><tr><td style="vertical-align:top"><p><u>Urogenital</u></p><p>&nbsp;&nbsp; Vaginal moniliasis</p><p>&nbsp;&nbsp; Vulvovaginitis</p><p>&nbsp;&nbsp; Vulvovaginal disorder</p><p>&nbsp;&nbsp; Trichomonal vaginitis</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>7.7</p><p>6.0</p><p>3.2</p><p>0...</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>10.4</p><p>&nbsp; 4.4</p><p>&nbsp; 5.3</p><p>&nbsp; 1.3</p></td></tr><tr><td style="vertical-align:top"><p><u>Body as a Whole</u></p><p>&nbsp;&nbsp; Moniliasis (body)</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1.3</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>&nbsp; 0.2</p></td></tr></tbody></table><p>&nbsp;</p><p>Other events occurring in &lt;1% of the clindamycin vaginal cream 2% groups include:</p><p><em>Urogenital system: </em>vaginal discharge, metrorrhagia, urinary tract infection, endometriosis, menstrual disorder, vaginitis/vaginal infection, and vaginal pain.</p><p><em>Body as a whole: </em>localized abdominal pain, generalized abdominal pain, abdominal cramps, halitosis, headache, bacterial infection, inflammatory swelling, allergic reaction, and fungal infection.</p><p><em>Digestive system: </em>nausea, vomiting, constipation, dyspepsia, flatulence, diarrhea, and gastrointestinal disorder.</p><p><em>Endocrine system: </em>hyperthyroidism.</p><p><em>Central nervous system: </em>dizziness and vertigo.</p><p><em>Respiratory system: </em>epistaxis.</p><p><em>Skin: </em>pruritus (non-application site), moniliasis, rash, maculopapular rash, erythema, and urticaria.</p><p><em>Special senses: </em>taste perversion.</p><p>&nbsp;</p><p>Pregnant Women:<strong><em> </em></strong>In a clinical trial involving pregnant women during the second trimester, 1.7% of 180 patients who received treatment for 7 days discontinued therapy due to drug-related adverse events. Medical events judged to be related, probably related, possibly related, or of unknown relationship to vaginally administered clindamycin phosphate vaginal cream 2%, were reported for 22.8% of pregnant patients. Events occurring in &ge;1% of patients receiving either clindamycin phosphate vaginal cream 2% or placebo are shown in Table 2.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="3" style="vertical-align:top"><p>TABLE 2 - Events Occurring in &ge;1% of Pregnant Patients Receiving</p><p>Clindamycin Phosphate Vaginal Cream 2% or Placebo</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dalacin</p><p>Vaginal Cream</p></td><td style="vertical-align:top"><p>Placebo</p></td></tr><tr><td style="vertical-align:top"><p>Event</p></td><td style="vertical-align:top"><p>7 DAY</p><p>n=180</p></td><td style="vertical-align:top"><p>7 Day</p><p>n=184</p></td></tr><tr><td style="vertical-align:top"><p><u>Urogenital</u></p><p>&nbsp;&nbsp; Vaginal moniliasis</p><p>&nbsp;&nbsp; Vulvovaginal disorder</p><p>&nbsp;&nbsp; Abnormal labor</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>13.3</p><p>6.7</p><p>1.1</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>7.1</p><p>7.1</p><p>0.5</p></td></tr><tr><td style="vertical-align:top"><p><u>Body as a Whole</u></p><p>&nbsp;&nbsp; Fungal infection</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1.7</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>0</p></td></tr><tr><td style="vertical-align:top"><p><u>Skin</u></p><p>&nbsp;&nbsp; Pruritus, non-application site</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1.1</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>0</p></td></tr></tbody></table><p>&nbsp;</p><p>Other events occurring in &lt;1% of the clindamycin vaginal cream 2% group include:</p><p><em>Urogenital system: </em>dysuria, metrorrhagia, vaginal pain, and trichomonal vaginitis.</p><p><em>Body as a whole: </em>upper respiratory infection.</p><p><em>Skin: </em>pruritus (topical application site) and erythema.</p><p><strong>Post-marketing Experience </strong></p><p><strong>&nbsp;</strong></p><p>Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p><p><strong>&nbsp;</strong></p><p>In the post-marketing period, there have been case reports of pseudomembranous colitis with the use of clindamycin phosphate vaginal cream.</p><p>&nbsp;</p><p><strong>Other clindamycin formulations:</strong></p><p><strong>&nbsp;</strong></p><p>Clindamycin vaginal cream affords minimal peak serum levels and systemic exposure (AUCs) of clindamycin compared to 100 mg oral clindamycin dosing. Although these lower levels of exposure are less likely to produce the common reactions seen with oral clindamycin, the possibility of these and other reactions cannot be excluded presently. Data from well-controlled trials directly comparing clindamycin administered orally to clindamycin administered vaginally are not available.</p><p>&nbsp;</p><p>The following adverse reactions and altered laboratory tests have been reported with the <strong>oral or parenteral </strong>use of clindamycin:</p><p>&nbsp;</p><p><em>Infections and Infestations: Clostridioides difficile</em> colitis</p><p>&nbsp;</p><p><em>Gastrointestinal: </em>Abdominal pain, esophagitis, nausea, vomiting, diarrhea and pseudomembranous colitis (<em>See</em> WARNINGS).</p><p>&nbsp;</p><p><em>Hematopoietic: </em>Transient neutropenia (leukopenia), eosinophilia, agranulocytosis, and thrombocytopenia have been reported. No direct etiologic relationship to concurrent clindamycin therapy could be made in any of these reports.</p><p>&nbsp;</p><p><em>Hypersensitivity Reactions: </em>Maculopapular rash and urticaria have been observed during drug therapy. Generalized mild to moderate morbilliform-like skin rashes are the most frequently reported of all adverse reactions. Cases of Acute Generalized Exanthematous Pustulosis (AGEP), erythema multiforme, some resembling Stevens-Johnson syndrome, have been associated with clindamycin. A few cases of anaphylactoid reactions have been reported. If a hypersensitivity reaction occurs, the drug should be discontinued.</p><p>&nbsp;</p><p><em>Liver: </em>Jaundice and abnormalities in liver function tests have been observed during clindamycin therapy.</p><p>&nbsp;</p><p><em>Musculoskeletal: </em>Cases of polyarthritis have been reported.</p><p>&nbsp;</p><p><em>Renal: </em>Acute kidney injury</p><p>&nbsp;</p><p><em>Immune System:</em> Drug reaction with eosinophilia and systemic symptoms (DRESS) cases have been reported.</p><p><u>&nbsp;</u></p><p><u>Reporting of suspected adverse reactions</u></p><p><u>&nbsp;</u></p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local requirements.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia:</strong></p><p><strong><em>&nbsp;</em></strong></p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp; Call center: 19999</p><p>&middot;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> </strong><strong>GCC</strong><strong> States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vaginally applied clindamycin phosphate vaginal cream 2% could be absorbed in sufficient amounts to produce systemic effects (see Special warnings and precautions for use).</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mechanism of Action</p><p>&nbsp;</p><p>Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly bacteriostatic. Although clindamycin phosphate is inactive <em>in vitro</em>, rapid <em>in vivo </em>hydrolysis converts it to active clindamycin.</p><p>&nbsp;</p><p><u>Resistance</u></p><p>Resistance to clindamycin is most often caused by modification of the target site on the ribosome, usually by chemical modification of RNA bases by point mutations in RNA or occasionally in proteins. Cross resistance has been demonstrated between lincosamides, macrolides and streptogramins B in some organisms. Cross resistance has been demonstrated between clindamycin and lincomycin.</p><p>&nbsp;</p><p><u>Antibacterial Activity</u></p><p>Culture and sensitivity testing of bacteria are not routinely performed to establish the diagnosis of bacterial vaginosis (<em>see</em><em> </em>INDICATIONS AND USAGE); standard methodology for the susceptibility testing of the potential bacterial pathogens, <em>Gardnerella vaginalis, Mobiluncus </em>spp., or <em>Mycoplasma hominis</em>, has not been defined.</p><p>&nbsp;</p><p>The following <em>in vitro </em>data are available but their clinical significance is unknown. Clindamycin is active <em>in vitro </em>against most isolates of the following organisms reported to be associated with bacterial vaginosis:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Bacteroides spp. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Gardnerella vaginalis &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Mobiluncus spp.</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Mycoplasma hominis</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Peptostreptococcus spp.</em></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Following a once a day intravaginal dose of 100 mg of clindamycin phosphate vaginal cream 2%, administered to 6 healthy female volunteers for 7 days, approximately 5% (range 0.6% to 11%) of the administered dose was absorbed systemically. The peak serum clindamycin concentration observed on the first day averaged 18 ng/mL (range 4 to 47 ng/mL) and on day 7 it averaged 25 ng/mL (range 6 to 61 ng/mL). These peak concentrations were attained approximately 10 hours post-dosing (range 4&ndash;24 hours).</p><p>Following a once a day intravaginal dose of 100 mg of clindamycin phosphate vaginal cream 2%, administered for 7 consecutive days to 5 women with bacterial vaginosis, absorption was slower and less variable than that observed in healthy females. Approximately 5% (range 2% to 8%) of the dose was absorbed systemically. The peak serum clindamycin concentration observed on the first day averaged 13 ng/mL (range 6 to 34 ng/mL) and on day 7 it averaged 16 ng/mL (range 7 to 26 ng/mL). These peak concentrations were attained approximately 14 hours post-dosing (range 4&ndash;24 hours).</p><p>&nbsp;</p><p>There was little or no systemic accumulation of clindamycin after repeated vaginal dosing of clindamycin phosphate vaginal cream 2%. The systemic half-life was 1.5 to 2.6 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carcinogenesis, Mutagenesis, Impairment of Fertility</p><p>&nbsp;</p><p>Long term studies in animals have not been performed with clindamycin to evaluate carcinogenic potential. Genotoxicity tests performed included a rat micronucleus test and an Ames test. Both tests were negative. Fertility studies in rats treated orally with up to 300 mg/kg/day (31 times the human exposure based on mg/m<sup>2</sup>) revealed no effects on fertility or mating ability.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sorbitan Monostearate, Polysorbate 60, Propylene Glycol, Stearic Acid, Cetostearyl Alcohol, Cutina CP (Mixed Fatty Acid Esters), Mineral Oil, Benzyl Alcohol, and Purified Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NA</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                21 months.

Do not use Dalacin Vaginal Cream after the expiry date which is stated on the carton / tube label after EXP. The expiry date refers to the last day of that month.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 25&deg; C. Protect from freezing.</p><p>&nbsp;</p><p>Keep out of the sight and reach of children.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clindamycin phosphate vaginal cream 2%, is supplied as follows:</p><p>40 gram tube (with 7 disposable applicators).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER

Pfizer Inc, New York, United States

MANUFACTURED BY

Pharmacia & Upjohn Company LLC
Kalamazoo, Michigan 49001, USA

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 May 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>